124 related articles for article (PubMed ID: 15163443)
1. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.
Alttoa A; Harro J
Eur Neuropsychopharmacol; 2004 Aug; 14(4):324-31. PubMed ID: 15163443
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
Wunderlich GR; DeSousa NJ; Vaccarino FJ
Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
[TBL] [Abstract][Full Text] [Related]
3. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
4. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
Vasar E; Harro J; Lang A; Pôld A; Soosaar A
Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion.
Higgins GA; Sills TL; Tomkins DM; Sellers EM; Vaccarino FJ
Pharmacol Biochem Behav; 1994 Aug; 48(4):1019-24. PubMed ID: 7972279
[TBL] [Abstract][Full Text] [Related]
6. Peripheral cholecystokinin A and cholecystokinin B receptors mediate stimulation of gastric pepsinogen and acid secretion following intracerebroventricular injection of cholecystokinin-8-sulphate.
Blandizzi C; Lazzeri G; Carignani D; Colucci R; Baschiera F; Tognetti M; Placanica G; Del Tacca M
Ital J Gastroenterol Hepatol; 1999; 31(6):440-8. PubMed ID: 10575559
[TBL] [Abstract][Full Text] [Related]
7. The effect of drugs acting on CCK receptors and rat free exploration in the exploration box.
Matto V; Harro J; Allikmets L
J Physiol Pharmacol; 1997 Jun; 48(2):239-51. PubMed ID: 9223028
[TBL] [Abstract][Full Text] [Related]
8. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
Crawley JN
J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
[TBL] [Abstract][Full Text] [Related]
9. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
Vasar E; Lang A; Harro J; Bourin M; Bradwejn J
Neuropharmacology; 1994 Jun; 33(6):729-35. PubMed ID: 7936110
[TBL] [Abstract][Full Text] [Related]
10. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.
Männistö PT; Lang A; Harro J; Peuranen E; Bradwejn J; Vasar E
Naunyn Schmiedebergs Arch Pharmacol; 1994 May; 349(5):478-84. PubMed ID: 8065461
[TBL] [Abstract][Full Text] [Related]
12. Examining the role of cholecystokinin in appetitive learning in the infant rat.
Weller A; Tsitolovskya L; Gispan IH; Rabinovitz S
Peptides; 2001 Aug; 22(8):1317-23. PubMed ID: 11457527
[TBL] [Abstract][Full Text] [Related]
13. Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.
Morel C; Ibarz G; Oiry C; Carnazzi E; Bergé G; Gagne D; Galleyrand JC; Martinez J
J Biol Chem; 2005 Jun; 280(22):21384-93. PubMed ID: 15772081
[TBL] [Abstract][Full Text] [Related]
14. The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopram-induced decrease of exploratory behaviour in rat.
Matto V; Harro J; Allikmets L
J Physiol Pharmacol; 1996 Dec; 47(4):661-9. PubMed ID: 9116333
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice.
Maletínská L; Maixnerová J; Matysková R; Haugvicová R; Pirník Z; Kiss A; Zelezná B
BMC Neurosci; 2008 Oct; 9():101. PubMed ID: 18939974
[TBL] [Abstract][Full Text] [Related]
16. 'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.
Rataud J; Darche F; Piot O; Stutzmann JM; Böhme GA; Blanchard JC
Brain Res; 1991 May; 548(1-2):315-7. PubMed ID: 1868342
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B
Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476
[TBL] [Abstract][Full Text] [Related]
18. The expression of behavioral sensitization to amphetamine: role of CCK(A) receptors.
DeSousa NJ; Wunderlich GR; De Cabo C; Vaccarino FJ
Pharmacol Biochem Behav; 1999 Jan; 62(1):31-7. PubMed ID: 9972842
[TBL] [Abstract][Full Text] [Related]
19. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
[TBL] [Abstract][Full Text] [Related]
20. Anti-exploratory effect of N-methyl-D-aspartate in elevated plus-maze. Involvement of NMDA and CCK receptors.
Vasar E; Harro J; Lang A; Soosaar A; Oöpik T; Kôks S; Sihver S; Volke V
Eur Neuropsychopharmacol; 1993 Mar; 3(1):63-73. PubMed ID: 8471831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
